These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15160292)

  • 1. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
    Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
    Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
    Hartman N; Voron SC; Hershman JM
    Headache; 1995; 35(7):430-1. PubMed ID: 7672963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
    Kamel N; Uysal AR; Cesur V; Erdoğan G; Başkal N
    Endocr J; 1995 Aug; 42(4):581-6. PubMed ID: 8556068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactinoma associated with transient growth hormone deficiency but persistent growth retardation.
    Schwartz ID; Hussey LM; Grunt JA; Howard CP
    J Pediatr Endocrinol; 1994; 7(1):69-73. PubMed ID: 8186829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
    Colao A; Loche S; Cappa M; Di Sarno A; Landi ML; Sarnacchiaro F; Facciolli G; Lombardi G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2777-80. PubMed ID: 9709946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of cabergoline in patients with prolactinemia and resistant or intolerant to bromocriptine].
    Velázquez-Chávez FJ; Tapia-González Mde L; González-Bárcena D
    Cir Cir; 2009; 77(3):173-7. PubMed ID: 19671268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactinoma and pregnancy: From the wish of conception to lactation.
    Maiter D
    Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperprolactinemia and lens opacities.
    Costagliola C; Mastropasqua L; Amato G; Carella C
    Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome and prolactinoma association.
    Yavasoglu I; Kucuk M; Coskun A; Guney E; Kadikoylu G; Bolaman Z
    Intern Med; 2009; 48(8):611-3. PubMed ID: 19367058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
    Shiraishi J; Koyama H; Shirakawa M; Ishikura R; Okazaki H; Kurajoh M; Shoji T; Moriwaki Y; Yamamoto T; Namba M
    Intern Med; 2016; 55(8):935-41. PubMed ID: 27086808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
    Levin G; Rottenstreich A
    Hormones (Athens); 2019 Jun; 18(2):137-139. PubMed ID: 30341577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
    Merola B; Colao A; Caruso E; Sarnacchiaro F; Briganti F; Lancranjan I; Lombardi G; Schettini G
    Gynecol Endocrinol; 1991 Dec; 5(4):267-76. PubMed ID: 1796748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible blindness caused by an invasive prolactinoma].
    Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C
    Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.